Little is known about the molecular impact of in vivo exposure to endocrine disruptors (EDs) on sperm structures and functions. We recently reported that the lifelong exposure of rats to the antiandrogenic compound vinclozolin results in low epididymal weight, changes in sperm kinematic parameters, and immature sperm chromatin condensation, together with the impairment of several fertility end points. These results led us to focus specifically on possible molecular abnormalities in sperm. Sperm samples were recovered from the frozen epididymides of rats exposed during the previous study. The proteins present in the samples from six exposed and six control rats were analyzed in pairs, by two-dimensional fluorescence difference gel electrophoresis, to investigate possible exposure-induced changes to sperm protein profiles. Twelve proteins, from the 380 matched spots observed in at least five gels, were present in larger or smaller amounts after vinclozolin exposure. These proteins were identified by mass spectrometry, and several are known to play a crucial role in the sperm fertilizing ability, among which, two mitochondrial enzymes, malate dehydrogenase 2 and aldehyde dehydrogenase (both of which were present in smaller amounts after treatment) and A-kinase anchor protein 4 (larger amounts of precursor after treatment). Finally, Ingenuity Pathway Analysis revealed highly significant interactions between proteins over-and underexpressed after treatment. This is the first study to show an association between in vivo exposure to an ED and changes to the sperm protein profile. These modifications may be at least partly responsible for the reproductive abnormalities and impaired fertility recently reported in this rat model of vinclozolin exposure.
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Experimental exposure to estrogenic or antiandrogenic endocrine disruptors (EDs) has repeatedly been shown to alter the male reproductive axis and/or fertility (for a review, see Sikka and Wang, 2008 and Gray et al., 2006) . On the other hand, associations have been reported between lower fertility, embryonic developmental abnormalities, and qualitative sperm abnormalities, such as low motility, impaired motion, a high proportion of morphologically abnormal sperm, chromatin immaturity, and DNA damage (Slama et al., 2002; Zini et al., 2008) . Several studies have shown that these abnormalities may result from exposure to EDs during gestation/lactation, at puberty or in adulthood (Pflieger-Bruss et al., 2006; Phillips and Tanphaichitr, 2008) . Estrogenic and antiandrogenic EDs have been reported to affect spermiogenesis and epididymal transit (Mantovani and Maranghi, 2005) . However, the precise impact of in vivo ED exposure on sperm structures and functions remains poorly understood from a molecular point of view.
Vinclozolin, a dicarboximide fungicide extensively used on fruits and vegetables, is a recognized contaminant of the human diet that is known to have the potential to function-essentially through its two main metabolites M1 and M2-as an androgen receptor (AR) antagonist (Kelce et al., 1994; Nellemann et al., 2003) . The administration of vinclozolin in vivo, at various doses, by various routes, and during diverse periods (gestation, lactation, puberty, and adulthood), induces a wide spectrum of reproductive defects (decrease in the anogenital distance, persistent nipples, low sperm counts, etc.) (Monosson et al., 1999; Yu et al., 2004) .
We have reported that daily oral exposure to 30 mg/kg vinclozolin from conception to adulthood impairs sperm head shaping and chromatin condensation in a rat model (Auger et al., 2004) . We recently reported a decrease in epididymal weight, changes to sperm kinematic parameters, and testis transcriptome and fertility abnormalities in the same experimental conditions (Eustache et al., 2009) . Based on our results, we hypothesized that vinclozolin exposure during the crucial steps of sperm cell formation and maturation might alter sperm protein composition, organization, and functions. Two-dimensional (2D) fluorescence difference gel electrophoresis (DIGE) and matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) have recently been used to determine testis/sperm protein profiles in various physiological/experimental studies (Aitken et al., 2007; Codrington et al., 2007; Dacheux et al., 2006; Klinefelter et al., 2004; Tinwell et al., 2007) .
In this study, we used these proteomic approaches to investigate whether chronic vinclozolin exposure modified sperm protein profiles and, if so, to identify the proteins displaying differential patterns of expression, and to determine whether they could at least partly account for the observed phenotypic changes and lower levels of fertility. We identified 12 proteins for which mean levels in rats exposed to vinclozolin differed from those in controls. Several of these proteins were structural or functional proteins involved in sperm maturation process and fertilizing ability.
MATERIALS AND METHODS
Chemicals, animals, and exposure conditions. Vinclozolin was extracted from the commercial formulation Ronilan (BASF, Levallois-Perret, France; final preparation purity > 95%) and dissolved in corn oil (Carrefour, Dijon, France). The exposure conditions have been described in detail elsewhere (Eustache et al., 2009) . Briefly, 8-week-old male and female specific pathogen free Wistar were purchased from Harlan (Harlan France, Gannat, France). They were allowed to acclimate to the conditions in the animal facility for 4 weeks before mating. Animals were maintained in accordance with the French Ministry of Agriculture guidelines for the care and use of laboratory animals. Ten females were randomly assigned to each of the two exposure groups, control versus vinclozolin, and mated with four males. If a vaginal sperm plug was observed, the females were exposed to 30 mg/kg vinclozolin or vehicle alone, by gavage, from gestational day 1 until the pups were weaned. From weaning until adulthood, the offspring were caged separately and exposed daily, by gavage, to 30 mg/kg vinclozolin or vehicle alone. Every 4 days, all the animals were weighed and inspected for possible abnormalities. On postnatal day 80, control and exposed rats were killed by inhalation of an overdose of anesthetic and immediately dissected to collect the left epididymis and other reproductive organs, which were weighed and stored at À80°C.
Sperm recovery and selection. Spermatozoa were retrieved from the frozen cauda epididymides. Briefly, each cauda epididymis was thawed on ice and placed in a Petri dish containing 2 ml of Eagle's medium supplemented with 1% bovine serum albumin (Sigma-Aldrich, St Quentin Fallavier, France). Multiple punctures were made in the tissue with a 20-gauge needle, and the cauda epididymis was then incubated for 15 min at 20°C and gently compressed with a dissecting forceps to facilitate sperm release. Microscopy of the collected liquid phases indicated that cells other than sperm were present. We therefore carried out a pilot study testing the various preparation techniques-simple centrifugation at 600 3 g for 10 min or centrifugation on density gradients at 600 3 g for 10 min on a single 47.5% Percoll (SigmaAldrich) phase or two Percoll phases (47.5 and 63.3%)-on control and exposed samples to determine which techniques gave the best compromise between purity and a sperm concentration appropriate for further protein analysis. As expected, centrifugation on density gradients resulted in lower levels of cell contamination (typically, 1-2% vs. 5-10% with the simple washing procedure), but generally with too low rate of sperm recovery for 2D DIGE. We therefore used the washing procedure (two steps, 10 min at 600 3 g) for all samples, and we assessed the postpreparation concentrations of sperm and cells by hemocytometry. This made it possible to select 12 sperm samples, 6 from control and 6 from exposed animals (no brothers in the exposed group and only two brothers in the control group), containing sufficiently large numbers of spermatozoa for further protein analyses based on matched pairs of exposed and control animals. The median level of cell contamination for the 12 samples was 5%, and interindividual and intergroup variability was low.
Protein extraction. Spermatozoa were solubilized by incubation in 2D sample buffer containing 20mM Tris, pH 8.5, 7M urea, 2M thiourea, 4% wt/vol 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) (SigmaAldrich), and 62.5mM dithiothreitol (DTT) (Sigma-Aldrich) and supplemented with protease inhibitor cocktail (Sigma-Aldrich) for 1 h at 4°C, on a rotary shaker. The samples were then centrifuged at 20,000 3 g for 30 min at 4°C, and the supernatant was removed. For DTT removal, the protein samples were treated with the 2D Clean-up Kit (GE Healthcare), according to the manufacturer's instructions. Precipitated proteins were then solubilized in lysis buffer without DTT and quantified with the 2D Quant Kit (GE Healthcare) before labeling with Cy dyes (GE Healthcare).
Assessment of differential protein profiles by 2D DIGE and image analysis. We assessed differential protein expression by matching protein samples from individual control and exposed animals and carrying out 2D DIGE with Cy3 labeling of control samples and Cy5 labeling of samples from exposed animals, or vice versa. A pilot study demonstrated that protein levels were not affected by the fluorochrome used and showed that the simultaneous switching of both fluorochromes in a control sample and an exposed sample had no effect on the protein ratio obtained (data not shown). We studied six control/exposed pairs, as summarized in Figure 1 . We labeled 50 lg of sample from each control or exposed animal with 400 pmol of Cy3 or Cy5, by incubation on ice in the dark for 30 min, followed by the addition of 10 mmol lysine to quench the reaction. An internal protein standard was used to ensure the precision of intergel comparisons of the exposed/control protein ratios. This internal protein standard was generated by pooling 25 lg each of all the individual samples from exposed and control animals and labeling with the Cy2 dye, following the same procedure as for the Cy3 and Cy5 dyes. Finally, for each gel, 150 lg of total protein corresponding to the mixture of the Cy3, Cy5, and Cy2 samples were adjusted to a total volume of 100 ll with sample buffer and cuploaded at the anodic end of immobilized pH gradient (IPG) strips, pH 3-11 non-linear 24 cm (GE Healthcare) that had been rehydrated (7M urea, 2M FIG. 1. Labeling and pairing design for 2D DIGE of protein samples from vinclozolin (VCZ)-exposed rats and control rats. The internal standard, consisting of a pool of 25 lg each of the individual samples for all exposed and control animals, was labeled with Cy2. This internal standard allowed further comparisons of differential protein levels between gels. We checked that unbalanced conditions could not affect the overall results, by labeling each individual protein sample with Cy3 or Cy5, with three of the six control samples and three of the six exposed samples randomly assigned to the Cy3 group, the remaining samples being labeled with Cy5 (gels C-H). Thus, each gel consisted of a sample of the internal standard (Cy2) mixed, in equal proportions, with a sample from a control animal stained with Cy3 or Cy5 and a sample from an exposed animal labeled with the other dye. 476 thiourea, 4% CHAPS, 62.5mM DTT, 0.5% IPG buffer, and trace amounts of bromophenol blue) overnight. Isoelectric focusing was carried out on an Ettan IPGphor (GE Healthcare) with a six-step voltage gradient, over a total of 80,000 V/h. The focused proteins in the IPG strips were frozen at À80°C or immediately equilibrated in two incubation steps, each lasting 15 min, at room temperature, in the equilibration buffer supplemented with 62.5mM DTT for reduction. They were then alkylated in the same buffer, but with 2.5% iodoacetamide instead of DTT (Görg et al., 1988) . For protein resolution in the second dimension, the strips were then applied to the top of 12% homogeneous polyacrylamide gels, and SDS-polyacrylamide gels electrophoresis was carried out on six gels simultaneously (Ettan DALTsix system; GE Healthcare), at 2.5 W per gel for 30 min, followed by 16 W/gel for 4 h. We then scanned for cyanin-labeled proteins, with a resolution of 100 lm, using a Typhoon 9400 Variable Mode Imager (GE Healthcare). Excitation wavelengths and emission filters specific for each of the cyanin dyes were chosen, and photomultiplier values were adjusted to optimize sensitivity, according to the manufacturer's recommendations. Protein spots were analyzed with Image Master 2D Platinum (GE Healthcare). The spots of each population of Cy2-, Cy3-and Cy5-labeled proteins were detected and quantified, and the three images obtained for a given gel were merged. Spot intensity was determined by summing for the pixels within each outlined spot and was recorded as a percentage of the total feature intensity on the image. Differences in protein levels were then expressed as a percentage of spot volume. Only spots well matched on at least five gels were subsequently examined. For these spots, percentages of spot intensity for exposed and control samples were plotted against each other. Most were projected onto the diagonal corresponding to a~1 ratio. We considered only those points that deviated from the diagonal on the scatter plot, consistent with possible differential protein production levels in the exposed/control pair. Based on the experimental design of the study and the relatively mild phenotypic differences observed between exposed and control animals (with a marked interindividual variability in phenotype end points; Eustache et al., 2009), we identified a 20% relative difference in spot volume between control and exposure conditions as a possibly relevant threshold (this threshold was suggested in several recent toxicogenomics studies, e.g., Alm et al., 2006; Choi et al., 2008 or Shi et al., 2010 . This approach was applied to all six gels and we decided that, for each selected spot, there was a possible impact of vinclozolin exposure if a difference ! 0.2 in the same direction was observed in at least two of the six gels, with no change in the opposite direction (with the same 0.2 threshold) observed on the remaining gels. For each selected protein, we then used paired nonparametric tests (Wilcoxon paired test) to compare the percentage of spots showing differential expression in exposed and control animals, for the six pairs. We set the significance threshold at 0.05, but nonetheless considered nonsignificant trends with p values of up to 0.15 due to the small number of gels tested and the marked interindividual variability observed.
Protein identification by MS. The resolved protein spots were visualized by staining with colloidal Coomassie Blue G-250 (Santa Cruz Biotechnology, Heidelberg, Germany) (Neuhoff et al., 1988) . Individual spots for which a difference of ! 0.2 in sperm protein levels was found between controls and exposed rats for at least two control/exposed pairs were excised from the gel and subjected to in-gel trypsin digestion, as described by Shevchenko et al. (1996) . Digestion was carried out according to a slightly modified version of the ZipPlate protocol (Millipore, Billerica, MA). Gel pieces were rinsed and destained by two incubations, for 20 min each, with 100mM ammonium bicarbonate (ABC) in 50% acetonitrile (ACN). The destained gel pieces were dried by incubation in 100% ACN for 15 min, and protein spots were incubated for 1 h at 56°C in 25mM ABC, pH 8.0, supplemented with 10mM DTT (Sigma-Aldrich, Steinheim, Germany). This solution was replaced by 55mM iodoacetamide (Sigma-Aldrich) in 25mM ABC, pH 8.0, and the gel pieces were incubated for 30 min at room temperature in the dark. Gel pieces were then washed twice in 25mM ABC and shrunk by incubation for 30 min with 25mM ABC in 50% ACN. The resulting alkylated gel pieces were dried by incubation in 100% CAN for 10 min. The dried gel pieces were reswollen by incubation with 20 ll of 12.5 lg/ml Sequencing Grade Modified Trypsin (Promega, Madison, WI) in 40mM ABC/10% ACN, pH 8.0, for 1 h at 4°C and were then incubated overnight at 37°C. Peptides were extracted by two incubations in 5% formic acid (FA)/55% ACN. Pooled extracts were desalted by passage through a C 18 phase on ZipPlate. Two elutions were performed to recover products from the C 18 phase: the first with 50% ACN/5% FA and the second with 90% ACN/ 5% FA. Pooled eluates were concentrated with a vacuum centrifuge (Eppendorf), and the peptides generated were resuspended in 3 ll of 5% FA for MS analysis. MS was carried out on a MALDI-TOF apparatus. We used the dried-droplet method: 1 ll of the sample was mixed on-plate with 1 ll of 5 mg/ml alpha-cyano-4-hydroxycinnamic acid in ACN/water/trifluoroacetic acid (50:50: 0.1%) (LaserBio Laboratories, Sophia Antipolis, France). Droplets were allowed to dry at room temperature. MALDI-TOF spectra were obtained by a reflectrondelayed extraction method, over a mass range of 500-3.500 Da, on a Voyager-DE-Pro mass spectrometer (PerSeptive Biosystems, Framingham, MA). Monoisotopic masses were calculated after internal calibration with tryptic autodigestion peptides or external calibration with a mixture of five external standards (PepMix1; Laserbio Laboratories) spotted as close as possible to the sample. Searches were carried out against the NCBInr protein database, with MS-FIT (University of California, San Francisco, CA) (Clauser et al., 1999) , ProFound (ProteoMetrics, New York, NY) (Zhang and Chait, 2000) , Mascot (Matrix Science Ltd, London, UK) (Perkins et al., 1999) , and AlDente (Expasy; Swiss Institute of Bioinformatics, Geneva, Switzerland). The carbamethylation of cysteins was allowed as a fixed modification, and the oxidation of methionine was allowed as a variable modification. Up to one missed tryptic cleavage was permitted, and a mass accuracy in the range of 25-50 ppm was used for all tryptic peptide mass searches. Combining the results obtained with different algorithms makes it possible to cross-validate and to consolidate peptide identification through the complementary use of several packages.
Network analysis. Pathway analysis was carried out for the proteins present in different amounts in the exposed and control samples. International protein index accession numbers were imported into Ingenuity Pathway Analysis (IPA) version 7.5-2202 (Ingenuity Systems, Mountain View, CA; http://www.ingenuity.com). The IPA database consists of a proprietary ontology representing biological objects, ranging from genes and proteins to molecular and cellular processes. Most known human genes are currently represented in the database. The proteins were classified on the basis of their location; cellular components; and reported or suggested biochemical, biological, and molecular functions. The identified proteins were mapped to the most significant networks generated from previous publications and public protein interaction databases. Practically, a p value calculated with the righttailed Fisher's exact test was used to yield a network's score and to rank networks according to their degree of association with our data set.
RESULTS

Proteins Detected and Proteins with Different Expression
Profiles in Control and Vinclozolin-Exposed Rats
The master gel contained about 1260 spots, 380 of which were repeatedly detected on at least five gels. We found that 25 of these 380 spots differed in intensity (spot volume) by at least 0.2 on at least two gels (Table 1 and example given in Fig. 2 ). High levels of protein overexpression (by a factor of at least 2) were found for only a few proteins, in only a few exposed animals. On some gels and for some proteins, an inverse ratio with respect to that obtained on other gels was found (see, e.g., in Table 1 , spot 15 in gel G or spot 13 in gel H). Marked differences in the overall expression profile of the 25 modified proteins were observed between gels, reflecting the interindividual variability: The percentage of proteins showing changes in levels on treatment was large for two gels (C and H), less marked for VINCLOZOLIN EXPOSURE AND SPERM PROTEINS 477 three gels (D, F, and G), and small for one gel (E). Finally, we found significant differences, at the 0.05 level, for proteins/spots 1, 15, 17, and 35. Given the small number of animals studied and the high degree of variability, we also considered trends associated with a p value of up to 0.10 (proteins/spots 3, 5, 10, and 22) or 0.15 (proteins/spots 8, 21, 25, and 27). Based on these criteria, six of the proteins were overexpressed and six were underexpressed following vinclozolin exposure.
Sperm Protein Identification by MS
Twenty-one of the 25 proteins displaying a change in level on treatment of at least 0.2, on at least two gels, were identified by MS (Tables 2 and 3 ). These proteins included enzymes involved in energy metabolism, such as malate dehydrogenase or aldehyde dehydrogenase (both present at lower levels in exposed animals, whereas the aldehyde dehydrogenase precursor was present at higher levels), and proteins involved in sperm head morphogenesis, periaxonemal organization, or capacitation, such as the AKAP4 precursor, phosphatidylethanolamine-binding protein (PEBP), or cytoplasmic actin (the levels of these three proteins being higher in exposed animals).
Protein Networks
The highest ranked network generated by the Ingenuity software (Fig. 3) had an F-score of 24 (p ¼ 10
À24
) and associated the following network functions: protein synthesis, energy production, Note. nd, not determined. ***p < 0.05; **p < 0.10; *p < 0.15 (differences in the % of spots between exposed and control rats were assessed by the nonparametric Wilcoxon test for paired values).
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and small molecule biochemistry. Most sperm proteins with differential production profiles following vinclozolin exposure were closely connected in the network, with two major nodes, HNF4A and SLC2A4, both reported to be involved in glucose transport (Angulo et al., 1998; Gupta and Kaestner, 2004) .
DISCUSSION
We provide here the first evidence that chronic exposure to an ED may alter sperm protein profile. The extent, direction, and nature of the changes in protein level after exposure to the antiandrogenic fungicide vinclozolin are consistent with the phenotypic alterations and impaired fertility recently reported for this rat model of vinclozolin exposure (Eustache et al., 2009 ). We will now consider certain methodological aspects and the proteins identified, focusing on their possible relevance to the phenotypic changes observed.
Several methodological factors may have contributed to the smallness of the difference in protein profile between exposed and control animals. One of these factors is the procedure used to retrieve the spermatozoa from the frozen cauda epididymis samples collected in the main study (Eustache et al., 2009) . Unfortunately, as the epididymis samples were frozen ''en bloc,'' we were obliged to disrupt the tissue to retrieve the spermatozoa, and microscopy showed there to be cells other than Fluorescence imaging of the same gel, according to the dyes associated with each protein spot (Cy3: control or exposed rat, Cy5: matched exposed or control rat, and Cy2: internal standard). (C) Examples of computer-generated three-dimensional representations of the spots, accounting for their size and intensity; this illustrates the differences in protein levels between a vinclozolin-exposed rat and an unexposed control rat; e.g., the protein of spot 15, identified by MS as aldehyde dehydrogenase (ALDH), is underexpressed, whereas the protein of spot 22, identified as the precursor of ALDH, is overexpressed. VINCLOZOLIN EXPOSURE AND SPERM PROTEINS spermatozoa in the cell suspensions. The level of cell contamination (~5%) was higher than that reported in studies based on flushing (< 1%; Baker et al., 2008) . Cell contamination increases experimental variation, possibly decreasing coverage of the proteome or leading to incorrect conclusions concerning specific differences in protein profiles. A mean of 5% cell contamination would therefore probably constitute a confounding factor decreasing the capacity of the proteomic analysis to identify proteins for which levels were modified by vinclozolin exposure. However, we believe that this 5% contamination level does not invalidate our results, although there is a risk of lowered proteome coverage. The identification of some proteins, such as AKAP4, is unlikely to be due to cell contamination due to their strict germ cell specificity.
The second methodological point concerns the experimental approach, based on the use of pairs of exposed/nonexposed samples rather than pools. Most proteome studies are based on pool samples. This approach is appropriate, provided that sufficient numbers of animals are analyzed and interindividual variation is low. However, the relatively high degree of phenotypic variability in the two groups in this study led us to conclude that the pooling of samples for the six exposed and for the six control animals would increase the risk of missing differences due to overall variability. We checked this assumption a posteriori: When the samples were pooled arithmetically, we were able to identify only five proteins for which a significant difference in levels was observed between exposed and control animals without any significant trend for other proteins (data not shown).
By contrast, the construction of random pairs of exposed/ control animals made it possible to account for individual variation and to detect a probable impact of the exposure, provided that the extent and direction of the difference were consistent in most animal pairs. This assumption was verified statistically. Overall, protein ratios were similar between gels, although they were occasionally very different (> 2 or < 0.5) for one particular protein on a particular gel. The most intriguing results, for which we have no explanation, concerned gels on which a specific protein gave a ratio, in some cases even a large ratio, that was the inverse of that obtained for the other gels (spot 23 for gel H or spot 15 for gel G, Table 1 ). However, this does not seem to reflect a methodological problem because similar inverse ratios were not found for other proteins in the same gel. The interindividual variability in sperm protein expression, which may be particularly large for certain proteins, is consistent with the relatively wide distribution of several phenotypic end points in both control and exposed animals in the main study despite average significant differences comparing both groups (Eustache et al., 2009) . Thus, as for some proteins for which we found an unexpected inversed ratio, a similar finding could be reached for any other end point after a random selection of a control/exposed pair of animals with phenotypic traits, which do not follow the general trend of the group. We now believe that the results obtained for several spots-with modifications of at least 0.2 level in the same direction, in at least half the gels, without contradictory data from the remaining gels (see Table 1 )-indicate the relevance of a given protein. Overall, the changes in levels of the proteins observed for the pairs of animals considered here and the corresponding phenotypic data from the main study (Eustache et al., 2009) were consistent, despite the low protein ratios obtained. These low ratios may be independent of methodological considerations and may also result from the nontoxicological dose of vinclozolin used, which was only one third to one fifth that used in many studies of the reproductive effects of vinclozolin. Major changes in protein levels were associated with low epididymis weight and impaired sperm motion and vice versa (Table 4) . The low epididymis weight in animals treated with vinclozolin, together with abnormal sperm motility in these animals, may reflect the negative impact of this compound on epididymis structures and functions. The acquisition of progressive motility and fertilizing ability by sperm requires the exposure of spermatozoa to the successive luminal microenvironments of the epididymis (Robaire and Hinton, 2002) and their transport along the epididymis, involving complex sperm protein modifications (Gatti et al., 2004) . AR gene expression is relatively constant throughout (Henderson et al., 2006) . It would therefore seem reasonable to assume that the changes in sperm protein levels observed here may result from AR antagonism by vinclozolin. Thanks to our previous study of the testis transcriptome in the same sample of animals (Eustache et al., 2009); we were able to compare the set of genes displaying modified expression in the testis with the set of sperm proteins with modified levels. Most of the transcripts corresponding to the proteins identified as displaying a change in level in this study were not identified in the testis, suggesting that the impact of vinclozolin exposure is posttesticular rather than testicular (data not shown). However, these two approaches are not directly comparable: total testis RNA levels in the entire testis from exposed and nonexposed pooled animals versus paired comparisons of sperm protein levels in exposed and nonexposed individual animals. Further investigations are therefore required to address this question and the possible modes of action accounting for the observed changes in protein levels.
Validation steps (Western blotting, immunochemistry, etc.) generally form an integral part of proteomic studies. Unfortunately, we have been unable to generate validation data. We tried to use an immunocytochemical approach, but this was unsuccessful because we found it difficult to obtain commercial antibodies suitable for use with our model, and then, sperm samples from control and exposed animals assessed with antibodies against either AKAP4 or PEBP proved to be unsuitable for image analysis (low level of light, superimpositions of sperm tails and heads, etc.). This absence of a validation step for data corroboration could be considered a weak point of this study. Should this weakness be at least partly compensated by the IPA results? We believe yes, and this has been verified mathematically. The insertion of our data set of modified proteins in IPA yielded a p value of 10 À24 (score 24). When performing a simulation analysis by repeated sampling of an identical number of randomly selected proteins, the four best p values were 10 À4 , 10 À10 , 10 À10 , and 10 À13 , that is to say, at best 11 log lower than our results. Therefore, the fact that the proteins found modified were clustered with a high rank in the IPA network (associating the functions ''protein synthesis, energy production, and small molecule biochemistry'') indicates that the proteins that were identified were not random and may interact biologically. Finally, IPA results (together with the phenotype modifications) are a good indicator that the identified proteins are relevantly and specifically modified by the vinclozolin exposure.
Following vinclozolin exposure, several trains of spots were detected and identified as the same protein (actin and aldehyde dehydrogenase). These findings probably reflect posttranslational modifications of the proteins, such as phosphorylation, glycosylation, or acetylation (Baker et al., 2008) , potentially affecting their three-dimensional structure and function. The nature and direction of change of several of the proteins with modified levels were compatible with the phenotypic modifications detected. Several of the proteins with differential production profiles were involved in energy metabolism pathways. These proteins included mitochondrial malate dehydrogenase 2 and aldehyde dehydrogenase; the levels of both these proteins being lower after treatment, whereas levels of the aldehyde dehydrogenase precursor were higher. These findings are consistent with the motility and kinematic impairment reported in the main study (Eustache et al., 2009) . Remarkably, both mitochondrial enzymes are androgen dependent (Brooks, 1978) and take part in the citric acid cycle, providing the cell with the adenosine triphosphate it requires. Higher levels of the precursor of one isomerase family member, protein disulfide isomerase (PDI), were observed after treatment. An isoform of PDI is produced in the developing acrosome and transported into the nucleus of mature spermatids and epididymal spermatozoa (Ohtani et al., 1993) ; it may play a key role in sperm-oocyte binding (Ellerman et al., 2006) . In other cells, PDI is involved in DNA-nuclear matrix anchoring (VanderWaal et al., 2002) . The A-kinase anchor protein 4 precursor, pro-AKAP4 (spot 35), was overexpressed in the spermatozoa of exposed rats. By contrast, the mature protein was present at lower levels in exposed rats, but this decrease did not exceed the 0.2 threshold (data not shown). In the spermatozoon, AKAP4, the most abundant protein in the fibrous sheath (Brown et al., 2004) , is synthesized as a precursor, pro-AKAP4, which is cleaved into mature AKAP4 during fibrous sheath assembly. The pro-AKAP4 molecule includes sequences targeting AKAP4 to a precise site in the developing sperm periaxonema, where it may interact directly with the outer microtubular doublets of the axonema (Nipper et al., 2006) . AKAP4 is involved in the expression and regulation of sperm progressive motility (Moretti et al., 2007) , and male mice lacking AKAP4 are infertile (Miki et al., 2002) . We therefore think that the high levels of AKAP4 precursor found in this study may be associated with the poor sperm motility reported in the main study, for the rats exposed to vinclozolin (Eustache et al., 2009) . Cytoplasmic beta-actin was moderately overproduced FIG. 3 . Highest ranked protein network after IPA of functional associations between the sperm proteins identified by MALDI-TOF. The F-score for this network-associating protein synthesis, energy production, and small molecule biochemistry functions was 24 (p ¼ 10
À24
). Most of the sperm proteins displaying a change in level after vinclozolin exposure are closely connected in the network through two major nodes, HNF4A and SLC2A4, both these proteins being reported to be involved in glucose transport. The network is graphically displayed with proteins as nodes and the biological relationships between the nodes as lines. Different shapes represent the functional classes of proteins. The length of a line reflects published evidence supporting the node-to-node relationship concerned. The color of the node indicates the degree of overexpression (red) or underexpression (green) of the corresponding protein. An IPA network is generated as follows: Once the proteins have been uploaded and the corresponding changes in expression values have been recorded, each protein identifier is mapped to its corresponding protein object in the IPA Knowledge Base (part of the IPA algorithm). @ protein precursor. 482 in exposed animals. The acrosomal space, equatorial and postacrosomal regions, and the tail contain actin (Virtanen et al., 1984) . Actin has been reported to be involved in the initiation of sperm motility, capacitation, acrosome reaction, sperm incorporation into the egg cytoplasm, and sperm nucleus decondensation (Breitbart et al., 2005; Lin et al., 2002) . High levels of this protein may therefore be associated with the motility problems and poor fertility reported for vinclozolinexposed rats in the main study. Finally, we cannot rule out the possibility of a link between changes in the levels of actin and AKAP4, and our previous data showing abnormal head morphometry and chromatin texture in vinclozolin-exposed animals (Auger et al., 2004) . Finally, we found slightly increased levels of PEBP in several samples from exposed rats. The PEBP1 form of this protein produced in the testis and epididymis is one of the major components of the sperm plasma membrane involved in membrane destabilization before capacitation (Fraser et al., 2006) . Unfortunately, we had no way of determining whether this was the form identified by MS (although our immunocytochemical validation tests showed weak labeling of spermatozoa with an anti-PEBP1). If the PEBP ''overexpressed'' in immature epididymal sperm from exposed rats was PEBP1, then this could suggest its possible participation to the decreased fertility of the rats exposed to vinclozolin.
In conclusion, this study provides the first evidence that a chronic oral exposure to the antiandrogenic food contaminant vinclozolin may alter the levels of several sperm proteins. Several of the proteins identified are known to be essential for fertilization. These results highlight the invaluable contribution of such proteomic approaches to the field of reproductive toxicology and our understanding of the molecular and cellular effects of exposure to EDs. 
